Dedicated to Advancing Pipelines
Our mission is to help our clients and partners translate their discovery biology output into preclinical candidates that have better chances of becoming marketed medicines in the least amount of time possible. We offer services in Lead Generation, Lead Optimization and early ADMET/PK studies.
Latest News!
NiKem Research introduces imaging mass spectrometry (MALDI TOF/TOF) for tissue distribution of drugs, metabolites and biomarkers.
List of patents and publications available - click here
A Complete Solution For Your Drug Discovery Needs
NiKem Research was born in 2001 by spinning out the very well trained, equipped and productive Milan research unit of GSK.
Imagine that decades of pharmaceutical drug discovery experience know-how and a state of the art facility becoming all of a sudden available on an outsourcing basis. Well, that was 8 years ago, and a lot has changed.
Today NiKem is more than tripled in size, has expanded and improved their state of the art facility, and has helped a portfolio of very satisfied clients advance their pipelines out of discovery and into the clinic. To learn more about how NiKem can help your company advance its pipeline, click here »